Table of Contents
- Clinical trials overview
- Who the studies were designed for
- What the trials measured
- Trial status and enrollment
- Key points for patients
Clinical trials overview
The available trial data show two early Phase 1 studies of Sisunatovir.[1][2] One study was designed to learn about safety, tolerability, and blood levels in infants and children with RSV lower respiratory tract infection.[1] The other study looked at the taste profile of different suspensions in healthy adults and also involved RSV-related study material.[2]
Who the studies were designed for
One trial focused on infants and children with RSV infection affecting the lower airways and lungs.[1] This is an important group because young children can be more affected by breathing infections.
The second trial enrolled healthy adult participants.[2] In that study, the main goal was not to treat illness, but to learn how the study medicine tasted in different forms.[2]
What the trials measured
The infant and child study measured treatment-emergent adverse events, which means health problems that start or get worse after the study medicine is given.[1] It also measured adverse events and serious adverse events that led to stopping the study medicine, plus clinically significant abnormal laboratory values, ECG parameters, and vital signs.[1]
The healthy adult study used a palatability questionnaire to score mouth feel, bitterness, sweetness, sourness, saltiness, tongue or mouth burn, and overall liking.[2] Palatability means how acceptable a medicine is to the senses, especially taste and mouth feel.[2]
Trial status and enrollment
The RSV lower respiratory tract infection study was listed as Withdrawn and planned to enroll 108 participants.[1] A withdrawn study means it did not move forward as planned before enough participants were enrolled or before completion.
The taste-profile study was listed as Completed and enrolled 12 healthy adults.[2] This small sample size fits an early study that is mainly meant to gather initial information.
Key points for patients
These trials are not large treatment studies yet; they are early research studies meant to learn basic information about Sisunatovir.[1][2] The research questions are different in each study: one is about safety in young children with RSV, and the other is about taste in healthy adults.[1][2]
For the child study, the main focus was on whether the study medicine could be given safely and whether the body showed any concerning changes in tests or heart tracing.[1] For the adult study, the main focus was whether the different suspensions were acceptable to taste and mouth feel.[2]
